Abstract
Controversies exist regarding the classification of the different clinical phases of chronic hepatitis B (CHB) because hepatitis B virus (HBV) DNA and alanine aminotransferase levels fluctuate over time.1,2 To improve the distinction of clinical phases and the associated spectrum of clinical outcome,3,4 hepatitis B surface antigen (HBsAg) levels may be of help.5–7 We hypothesize that HBV genotype specific HBsAg levels are needed for the identification of different clinical HBV disease phases.7
| Original language | English (US) |
|---|---|
| Pages (from-to) | 259-261 |
| Number of pages | 3 |
| Journal | Clinical Gastroenterology and Hepatology |
| Volume | 18 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2020 |
Bibliographical note
Publisher Copyright:© 2020 AGA Institute
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS